Home/Arcellx/Rami Elghandour
RE

Rami Elghandour

Chairman and Chief Executive Officer

Arcellx

Arcellx Pipeline

DrugIndicationPhase
Anitocabtagene Autoleucel (anito-cel)Relapsed/Refractory Multiple MyelomaPhase 2
ACLX-001Relapsed/Refractory Multiple MyelomaPhase 1
ACLX-002Relapsed/Refractory Acute Myeloid Leukemia (AML) & High-Risk MDSPhase 1
ACLX-003AML/MDSPreclinical
ACLX-004AML/MDSPreclinical
HCC ProgramHepatocellular CarcinomaDiscovery
SCLC ProgramSmall Cell Lung CancerDiscovery